Institutional shares held 1.94 Million
0 calls
0 puts
Total value of holdings $444M
$0 calls
$0 puts
Market Cap $20.5B
89,600,000 Shares Out.
Institutional ownership 2.17%
# of Institutions 95


Latest Institutional Activity in LH

Top Purchases

Q3 2024
Ethic Inc. Shares Held: 1.42K ($324K)
Q3 2024
Oak Associates LTD Shares Held: 63.7K ($14.6M)
Q3 2024
Jacobs & CO Shares Held: 25.2K ($5.76M)
Q3 2024
Cibc World Markets Corp Shares Held: 11.4K ($2.6M)
Q3 2024
Ironwood Investment Counsel, LLC Shares Held: 20.5K ($4.68M)

Top Sells

Q3 2024
Sterling Capital Management LLC Shares Held: 0 ($0)
Q3 2024
B. Metzler Seel. Sohn & Co. Holding Ag Shares Held: 0 ($0)
Q3 2024
Penobscot Investment Management Company, Inc. Shares Held: 8.48K ($1.94M)
Q3 2024
Sawyer & Company, Inc Shares Held: 4.93K ($1.13M)
Q2 2024
Deka Bank Deutsche Girozentrale Shares Held: 108K ($24.8M)

About LH

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.


Insider Transactions at LH

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
224K Shares
From 22 Insiders
Exercise of conversion of derivative security 224K shares
Sell / Disposition
190K Shares
From 22 Insiders
Payment of exercise price or tax liability 76K shares
Open market or private sale 114K shares

Track Institutional and Insider Activities on LH

Follow LABORATORY CORP OF AMERICA HOLDINGS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LH shares.

Notify only if

Insider Trading

Get notified when an Laboratory Corp Of America Holdings insider buys or sells LH shares.

Notify only if

News

Receive news related to LABORATORY CORP OF AMERICA HOLDINGS

Track Activities on LH